بررسی اثرتشخیصی تکنسیوم 99 و متیلن بلو در بررسی گرفتاری گره لنفاوی sentinel در بیماران مبتلا به سرطان اندومتر کم خطر استاد راهنما: سرکار خانم دکترفریبا.

Slides:



Advertisements
Similar presentations
Dr Cheung Chi Ying Genevieve
Advertisements

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
OPTIONAL LOGO HERE Prevalence of endometrial cancer in symptamatic women with thickened endometrium Dr Maheswari SRINIVASAN MRCOG SpR, Mrs Shagaf BAKOUR.
Toward a molecular intra-operative diagnosis of SLN invasion R Garrel 1, V Burcia 1, J Solassol 2, V Costes 3, E Barbotte 4, D DeVerbizier 5, C Cartier.
Mechanism of Action Combidex in MR Imaging Mukesh Harisinghani, MD Department of Radiology, Massachusetts General Hospital.
ICD-10 Getting There….. Pathology. What Physicians Need To Know Claims for ambulatory and physician services provided on or after 10/1/2015 must use ICD-10-CM.
 - an important step in surgical staging for uterine cancer (FIGO 1988)  Stated as 
Sentinel Lymph Node Biopsy in Melanoma
Cervical Cancer Keith Unger 2/24/06. Clinical History 47 yo F with vaginal bleeding and pelvic pain On exam, large cervical mass with parametrial involvement.
S ENTINEL L YMPH N ODE M ICROMETASTASIS IN B REAST C ANCER Anthony Fong Yan Chai Hospital.
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
Endometrial Cancer Screening for Cancer in Women.
Carcinoma of the Endometrium1 CARCINOMA OF THE ENDOMETRIUM Wen Di, M.D. , Ph.D.
Female Genital Tract 1-Vulva 2-Vagina 3-Cervix 4-Uterine corpus
Post Menopausal Bleeding
CARCINOMA OF THE ENDOMETRIUM
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Endometrial Cancer ASSOCIATE PROFESSOR Iolanda Blidaru MD, PhD.
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
Sentinel Node Biopsy : the way forward Hemant Singhal MS FRCSEd FRCS(Gen) FRCSC Consultant Surgeon Northwick Park & St Marks Hospital Senior Lecturer,
Background Sentinel lymph node biopsy has been recently introduced in the clinical setting because it is highly accurate in predicting the lymph node status.
Less Radical Surgery for Patients with Early-Stage Cervical Cancer Dr Marie Plante NCIC CTG, Cervix Working Group GCIG meeting Belgrade, Oct 10-11, 2009.
In the name of God Isfahan medical school Shahnaz Aram MD.
Endometrial Carcinoma
EVALUATION OF LYMPH NODES & PATHOLOGIC EXAMINATION FOR BREAST CASES Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
Cancer of Cervix Shashi. Oct-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. US Statistics: US Statistics: Leading.
Endometrial Cancer By Jessica Hall. Symptoms Unusual vaginal bleeding or discharge Difficult or painful urination Pain during intercourse Pain in the.
TEMPLATE DESIGN © Endometrial large cell neuroendocrine carcinoma : a case report Reina Sato, Aiko Kawano, Hiroyuki Shigeta.
2011 ACRIN Annual Meeting ACRIN 6671/GOG 0233 REVIEW RESULTS ACRIN PI: M. ATRI GOG PI: M. GOLD FERUMOXTRAN-10 MRI REVIEW RESULTS ACRIN PI: M. ATRI GOG.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Factors affecting failed localisation and false-negative rates of ex-vivo sentinel lymph node mapping in colorectal cancer. Sommariva A, Gnocato B, Tollot.
Synchronous Ovarian and Endometrial Carcinomas; An Unusual Outcome of First Trimester Ultrasound Scanning. Karl McPherson, Rhona Lindsay, Jaimie Thiesen-Nash,
M.D. Browning, M.D. ‘77.  Most Common Cancer of Female Reproductive System  60,000/year with 10,000 deaths  Normal Cells in the Endometrium.
Management of early stage cervical cancer
ELIGIBILITY CRITERIA- Summarised
Malignant disease of the body of the uterus
An introduction to Breast Cancer and Unmet Clinical Needs
Malignant disease of the body of the uterus
Comparison of the primary cesarean hysterotomy scars after single- and double-layer interrupted closure SOROMON KATAOKA, FUMIE TANUMA, YUTAKA IWAKI, KURUMI.
CORRELATION OF PHYSICAL EVALUATION AND MRI OF CERVICAL LYMPH NODE WITH HISTOPATHOLOGICAL FINDINGS IN ORAL SQUAMOUS CELL CARCINOMA: AN AMBIDIRECTIONAL STUDY.
COMPARISON OF RISK OF MALIGNANCY INDICES AND ASSESSMENT OF DIFFERENT NEOPLASIAS IN THE ADNEXA (ADNEX) MODEL AS PREOPERATIVE MALİGNANCY EVALUATION METHODS.
Dr . Saadeh Jaber OBGYN consultant 2010
Post Menopausal Bleeding
Zehra Nihal Dolgun, Ahmet Salih Altintas, Cihan Inan, Petek Balkanli
CARCINOMA OF THE ENDOMETRIUM
1 LINFOADENECTOMIA Alessandro Volpe Università del Piemonte Orientale
Overzicht activiteiten werkgroep medicamenteuze therapie
Sentinel lymph node and lymphatic mapping using indocyanine green for endometrium cancer: a case report. Suat Karatas, Veysel Sal, Emel Canaz, Meltem.
Cervical Cancer Tiffany Smith HCP 102.
Amant F – Gynecological Oncology - UZ Gasthuisberg, Leuven
ENDOMETRIAL HYPERPLASIA
Malignant disease of the body of the uterus
Prof. Shaila Anwar Professor Obs & Gynae
Erica V. Bloomquist, MD Heather Wright, MD
Prof.S.M.Haider Faisal Hameed Wahab Kadri
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Uterine cancer Uterine mesenchymal neoplasms
VALUES OF ELASTOGRAPHY IN DIAGNOSIS OF THYROID CANCER
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Pericervical injection of 99mTc-Nanocolloid IS superior to peritumoral injection for sentinel lymph node detection in SPECT/CT Dr. Martin Weiss Department.
An Audit on Complex hyperplasia reporting at Derriford Hospital
EVALUATING THE EARLY EFFECTS OF TRU-CUT BIOPSY UNDER CT GUIDANCE IN PATIENTS WITH LUNG TUMOUR AT NATIONAL LUNG HOSPITAL. Dr. Phuong Ngoc Anh National Lung.
Ganim Khatib, MD Çukurova University Gynecological Oncology
Management of endometrial cancer found on routine hysterectomy for benign disease Prof Dr M Anıl Onan MAY ANTALYA.
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
ENDOMETRIAL CARCINOMA
Presentation transcript:

بررسی اثرتشخیصی تکنسیوم 99 و متیلن بلو در بررسی گرفتاری گره لنفاوی sentinel در بیماران مبتلا به سرطان اندومتر کم خطر استاد راهنما: سرکار خانم دکترفریبا بهنام فر رزیدنت: متینا جعفری

اهمیت موضوع: سرطان اندومتر جزء یکی از شایع ترین سرطان های زنان می باشد.اقدام جراحی اولیه برای سرطان اندومتر شامل هیسترکتومی توتال همراه با سالبنگواووفوکتومی است.یکی از تناقضات در درمان کانسر اندومتر برداشتن یا برنداشتن گره های لنفاوی لگنی و باراآئورتیک می باشد و تعیین دقیق بیماران مبتلا به کانسر اندومتر که از برداشتن گره های لنفاوی سود می برند از موضوعات مورد بحث و مطالعه روز دنیاست.برداشتن کامل گره های لنفاوی عوارض شدیدی می تواند داشته باشد که نه تنها کیفیت زندگی فرد بلکه ادامه درمان و شروع اقدامات کمکی را به تاخیر می اندازد.مطالعات مختلف این فرضیه را مطرح کرده اند که بیوبسی از گره لنفاوی سنتینل می تواند از لنفادنکتومی توتال غیر ضروری جلوگیریکند

برای تعیین محل گره لنفاوی سنتینل از روش هایی مانند متیلن بلو و ماده نشان دار (تکنسیوم 99 و ایندوسیانین گرین) استفاده می شود. هدف مطالعه : بررسی ارزش تشخیصی تکنسیوم 99 و متیلن بلو در بررسی گرفتاری گره لنفاوی سنتینل در بیماران مبتلا به کانسر اندومتر کم خطر

Endometrial cancer : The most prevalent genital related cancer of females and fourth most common malignancy of them. Up to 80% are endometroid type. Risk factors:long term esterogen exposure as it may increase chance of atypical endometrial hyperplasia-Aging-polycystic ovarian disease-obesity-metabolic syndrom and use of Tamoxifen. Most common symptoms:Abnormal uterine bleeding The only curable treatment : Surgical(Total hysterectomy and bilateral salpingo- oophorectomy-in some conditions omentectomy and retroperitoneal lymph node dissection)

Methods and materials : This study was a cross-sectional study conducted on 14 patients with low-grade endometrial cancer referred to Al-Zahra and Shahid Beheshti Hospitals in 20I6-17 Inclusion criteria: 1)endometrial cancer with clinical grade I 2)stage 1b of endometrial cancer 3) histological report of adenocarcinoma 4) patients' willing for participation in this study

Exclusion criteria : 1) hypersensitivity to technetium-99 and methylene blue 2) history of previous surgery or lymphadenectomy that has altered lymphatic drainage of the uterus (eg, myomectomy) 3) pregnancy.

Methods & Materials : 18-24 hours before operation, patients underwent Tc-99 injection. Injection region of Tc-99 was 3, 6, 9 and 12 o'clock regions of cervix. Each injection was done using spinal 25 gauge needle. In each region, one milliliter of Tc- 99 was injected in two depth of cervical submocusal area (2-3 mm depth) and cervical stromal region (3-4 cm depth). In the next day, during operation tc-99 was detected was done by using manual gamma probe (Sergeoguide 2, produced by Iran) to find hot nodes. Methylene blue injection was done using spinal 25 gauge needle, injected to 3 and 6 o'clock region of cervix in operating room. Blue nodes were detected by naked eyes.

Then, in next day, all patients underwent total hysterectomy, bilateral salpingo-oophorectomy and total pelvic lymphadenectomy regardless of being detected as SLNs by methylene blue/hot nodes or not. Lymph node samples were sent for frozen section and assessment of positive/negative metastasis. Then data were analyzed with IBM SPSS20 - United States software. Descriptive data were reported in mean ± standard deviation

Table-1. Characteristics of study population Age (mean±std) 60.64±9.18 Methylene blue (Number of diagnosed SLNs) 15/80 (18.8%) TC-99 (Number of diagnosed SLNs) 10/80 (12.5%) Methylene blue + TC-99 (Number of diagnosed SLNs) 5/80 (6.3%) Lymphovascular invasion (lymph node) Present 2 (14.3%) Absent 12(85.7%) Table-1. Characteristics of study population Lymph node location (N) Right internal iliac 27 (33.8%) Left internal iliac 14 (17.5%) Right external iliac 3 (3.8%) Left external iliac 9 (11.3%) Right common iliac 6 (7.5%) Left common iliac 8 (10%) Right obturator Left obturator 5 (6.3%) Table 2. Location of sentinel lymph nodes

Negative predictive value   Methylene blue TC-99 Methylene blue + TC-99 Detection rate 100% Sensitivity Negative predictive value False negative 0% Table-3. Detection rate.Sensitivity, negative predictive value and false negative of different tests

Other studies : Lymphatic mapping and sentinel node biopsy in endometrial cancer—a feasibility study using cervical injection of radiotracer and blue dye kadkhodayan S.shirvani Z.Hasanzadeh M – 2014 Result: studied patients with high grade endometrial cancer and reported 87% intra operative detection of SLN.

Study 2: Establishing a sentinel lymph node mapping algorithm for the treatment of early endometrial cancer Cormier B, Diaz JP, Shih K, Sampson RM, Sonoda Y, Park KJ, et 2016 Result : total of 21% of SLN s were detected using both blue dye & TC-99

Study 3: Sentinel lymph node mapping in early stage of endometrial and cervical cancer Allameh T, Hashemi V, Mohammadizadeh F, Behnamfar F. 2015 Result : detection rate of metastatic disease :80% sensitivity :100% NPV:100% false negative :0

Discussion : Metastatic involvement : 2/14 (14.3%) = consistent with other studies all dissected SLN regardless of intra operative method : 25% is similar to study of Beatrice cormier and opposite of kadkhodayan et al studies and Niikura et al studies (because their patient with high grade endometrial carcinoma) site of injection: cervical- fundal & sub-endometrial = consistent with other studies Location of lyph node: most common: internal iliac – no para aortic = consistent with other studies

SLN found by each test(methylene blue-Tc99-combination of methylene blue and Tc-99) = opposite of other studies Detection rate-sensitivity-NPV-False negative = similar to other studies Adverse effect :No = similar to other studies Although lymph node dissection in low grade endometrial cancer is contra versial but it is possible to have diverse diagnosis based on dilation and curettage in comparison to pathology. It means that pathological diagnosis maybe high garde tumor. Thus sentinel node detection can provide diagnosis of metastatic nodes and help prevent more tumor invasion.

Conclusion: Our study found that methylene blue,tc99 and combination of them had acceptable rate of SLNs detection due to low probability of metastasis in low grade endometrial cancers with detection rate of 100%. sensitivity of 100%. negative predictive value of 100% and false negative of 0%. Further studies with larger population for pre-operative SLNs detection in low grade endometrial cancers are recommended.

تقدیم به دستان پر مهر پدرم و تقدیم به سخاوت بی پایان مادرم که رسم زندگی را به من آموختند و تقدیم به تمامی بیمارانی که به بهای دردشان آموختم و به خواهران و برادر عزیزم و تقدیم به همه ی دوستان خوبم وهمه ی کسانی که دوستم دارند

با سپاس فراوان از: سرکار خانم دکتر فریبا بهنام فر استاد راهنمای گرامی جناب آقای دکتر مسعود مصلحی و سرکار خانم دکتر نوشین افشار مقدم اساتید مشاور ارجمند و سایر اساتید محترم که هر یک به نحوی در تعالی اینجانب به درجات بالاتر سهم داشتند.